loading page

Subcutaneous Adipose Tissue: Implications in Dermatological Diseases and Beyond
  • +4
  • Reihane Ziadlou,
  • Ganesh N. Pandian,
  • Jürg Hafner,
  • Cezmi Akdis,
  • Georg Stingl,
  • Emanual Maverakis ,
  • Marie-Charlotte Brüggen
Reihane Ziadlou
Universitat Zurich Medizinische Fakultat
Author Profile
Ganesh N. Pandian
Kyoto University
Author Profile
Jürg Hafner
UniversitatsSpital Zurich Dermatologische Klinik
Author Profile
Cezmi Akdis
Universitat Zurich Medizinische Fakultat
Author Profile
Georg Stingl
Medical University of Vienna
Author Profile
Emanual Maverakis
University of California Davis Department of Dermatology
Author Profile
Marie-Charlotte Brüggen
Universitat Zurich Medizinische Fakultat

Corresponding Author:[email protected]

Author Profile


Subcutaneous adipose tissue (SAT) is the deepest component of the three-layered cutaneous integument. While mesenteric adipose tissue-based immune processes have gained recognition in the context of the metabolic syndrome, SAT has been traditionally considered primarily for energy storage, with less attention to its immune functions. SAT harbors a reservoir of immune and stromal cells that significantly impact metabolic and immunologic processes not only in the skin, but even on a systemic level. These processes include wound healing, cutaneous and systemic infections, immunometabolic and autoimmune diseases, inflammatory skin diseases, as well as neoplastic conditions. A better understanding of SAT immune functions in different processes, could open avenues for novel therapeutic interventions. Targeting SAT may not only address SAT-specific diseases but also offer potential treatments for cutaneous or even systemic conditions. This review aims to provide a comprehensive overview on SAT’s structure and functions, highlight recent advancements in understanding its role in both homeostatic and pathological conditions within and beyond the skin, and discuss the main questions for future research in the field.
09 Feb 2024Submitted to Allergy
09 Feb 2024Assigned to Editor
09 Feb 2024Submission Checks Completed
11 Feb 2024Reviewer(s) Assigned
07 Mar 2024Review(s) Completed, Editorial Evaluation Pending
07 Mar 2024Editorial Decision: Revise Minor